Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange launched the full version of the Algopack service

2/18/25 MOEX

Severstal will shut down BF-4 at CherMK for overhaul repair

2/18/25 CHMF

Ozone Pharmaceuticals sales in 2024 grew by 13%

2/18/25 OZPH

Softline's turnover in 2024 will grow by 32%

2/18/25 SOFL

MTS winds down investment in video platform Nuum

2/18/25 MTSS

Binnopharm Group enters the hormonal drugs market

2/18/25 AFKS

T-Bank reported for January 2025

2/17/25 T

ARS Smart Robotics has opened a pre-IPO round of investment raising

2/17/25 OTCI

PhosAgro records new monthly production volume

2/17/25 PHOR

Lenta opens third STM test center

2/17/25 LENT